The efficacy of this agent for maintenance of remission in patients with UC has not been systematically evaluated. Objectives The primary objective was to systematically review the efficacy and safety of curcumin for maintenance of remission in UC. Search methods A computer-assisted literature search of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and the Cochrane Inflammatory Bowel Disease Specialized Trial Register was performed on July 11, 2012 to identify relevant publications. 